$1.75
$0.00 (0.00%)
End-of-day quote: 05/11/2024
NYSEAM:CATX
Perspective Therapeutics Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| BDX | Becton Dickinson and Co | NYSE | Outperform | $235.67 | $284.47 | 0.00% | 8 | $68.11B |
| EKTA B | Elekta AB (publ) | OM | Hold | kr80.35 | kr83.00 | 0.00% | 3 | kr30.26B |
| NWBO | Northwest Biotherapeutics | OTCPK | - | $0.49 | $8.00 | 0.00% | 0 | $560.52M |
| ARAY | Accuray Inc | NASDAQ | Buy | $1.62 | $8.75 | 0.00% | 0 | $215.20M |
| CAPR | Capricor Therapeutics | NasdaqCM | Buy | $5.30 | $13.50 | 0.00% | 1 | $166.97M |
| FBIO | Fortress Biotech | NasdaqCM | Buy | $1.67 | $67.50 | 0.00% | 1 | $33.66M |
| PIRS | Pieris Pharmaceuticals | NasdaqCM | - | $11.15 | $7.00 | 0.00% | 0 | $13.80M |
| ONTX | Onconova Therapeutics | NasdaqCM | Buy | $0.68 | $11.50 | 0.00% | 0 | $13.75M |
| CYCC | Cyclacel Pharmaceuticals | NasdaqCM | Outperform | $2.27 | $240.00 | 0.00% | 0 | $3.32M |
